Danone Stock Slumps on Infant Formula Contamination Concerns
By Aimee Look
Shares in Danone fell as much as 12% after authorities in Singapore halted sales of a baby formula brand, citing potential contamination with the bacteria cereulide.
The stock later pared some losses to trade down 6.8% at 68.86 euros in European afternoon trading on Wednesday.
The French food company said in a statement that the Singapore Food Agency requested it block a batch of its Dumex Dulac, which it manufactures in the country, as a precaution. Danone said its controls have not identified any irregularities or issues regarding Bacillus cereus, which can produce cereulide.
"All our products are manufactured in line with strict food safety and quality standards and undergo rigorous testing before leaving our factories," it said. "All controls confirm that our products are safe and fully compliant with international and local regulations."
The concern over Danone baby formula follows a mass recall of baby formula by Nestle in various countries--for also potentially containing the same toxin--which can cause nausea and vomiting.
Danone's share price reaction, and the Nestle recall will shift investor focus onto what ingredients are used in the manufacturing process for the whole industry, analysts at J.P. Morgan wrote in a note to clients.
Though the sales exposure to Dumex Singapore is minimal for Danone, the market reaction reflects larger concern that nutrition products will be hit by similar recalls, the analysts said.
Write to Aimee Look at aimee.look@wsj.com
(END) Dow Jones Newswires
January 21, 2026 09:26 ET (14:26 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
